T. Rowe Price Health Care ETF Rating $25.24 +0.07 (+0.27%) As of 08/29/2025 Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsTrendsBuy This Stock T. Rowe Price Health Care ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.TMED Aggregate RatingModerate Buy 2.72Holdings in TMED have an aggregate rating of Moderate Buy based on 464 analyst ratings issued in the past year covering 25 companies (71.7% of the portfolio).TMED Aggregate Price Target$25.24High Prediction$25.24Average Prediction$25.24Low Prediction$25.24Holdings in TMED have an aggregate price target of $25.24 and a range of $25.24 to $25.24 covering 25 companies (71.7% of the portfolio).TMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by T. Rowe Price Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 TMED Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings13.20%LLYEli Lilly and Company$732.41+0.1%5 of 5 stars2.67$950.17 29.7%24Trending NewsAnalyst UpgradeAnalyst Revision7.48%UNHUnitedHealth Group$309.77+2.5%4.9438 of 5 stars2.50$353.00 14.0%24Positive News6.40%ABBVAbbVie$210.25+1.1%4.7082 of 5 stars2.92$214.95 2.2%264.65%ABTAbbott Laboratories$132.59+0.9%4.8868 of 5 stars2.91$144.47 9.0%22Positive News4.20%DHRDanaher$206.09+0.4%4.9209 of 5 stars2.85$247.61 20.1%20Positive News4.01%BDXBecton, Dickinson and Company$192.84+0.8%4.4283 of 5 stars2.36$211.44 9.6%11Positive News3.88%ISRGIntuitive Surgical$473.30-0.1%4.9567 of 5 stars2.60$595.95 25.9%20Positive News3.40%GILDGilead Sciences$112.97+0.4%4.9696 of 5 stars2.88$115.39 2.1%26Positive NewsInsider Trade2.41%ELANElanco Animal Health$18.38-0.4%2.7583 of 5 stars2.78$17.33 -5.7%9Positive NewsHigh Trading Volume2.01%REGNRegeneron Pharmaceuticals$580.70+0.2%4.7849 of 5 stars2.81$817.67 40.8%27Positive News1.91%CVSCVS Health$73.17+1.4%4.9491 of 5 stars3.05$77.56 6.0%22Insider Trade1.70%EWEdwards Lifesciences$81.48+0.3%4.3288 of 5 stars2.65$85.90 5.4%26Positive NewsAnalyst Upgrade1.68%CYTKCytokinetics$35.33-5.4%3.6432 of 5 stars2.93$71.58 102.6%15Positive News1.66%ASNDAscendis Pharma A/S$194.27+0.2%3.3399 of 5 stars3.00$243.36 25.3%15News CoveragePositive News1.65%HUMHumana$303.90+2.0%4.0364 of 5 stars2.30$283.29 -6.8%23Positive News1.64%AAgilent Technologies$125.63+0.5%4.7653 of 5 stars2.50$139.25 10.8%12News CoverageEarnings ReportAnalyst ForecastAnalyst Revision1.36%HOLXHologic$67.12+0.8%4.8876 of 5 stars2.59$78.00 16.2%17Positive NewsAnalyst Downgrade1.27%MTDMettler-Toledo International$1,302.74+1.5%4.2777 of 5 stars2.50$1,311.11 0.6%10Positive News1.20%CORCencora$291.51+0.6%4.5633 of 5 stars2.75$311.25 6.8%12Positive NewsAnalyst Revision1.16%BIIBBiogen$132.22-0.3%4.8647 of 5 stars2.34$185.74 40.5%32Positive News1.03%COOCooper Companies$67.39+4.4%4.285 of 5 stars2.92$86.64 28.6%12Earnings Report1.01%ACLXArcellx$69.39-1.2%1.8733 of 5 stars3.13$114.31 64.7%15News CoveragePositive News0.96%MCKMcKesson$686.44+0.8%4.4281 of 5 stars2.85$725.10 5.6%13Positive NewsAnalyst Revision0.93%DXCMDexCom$75.34+0.3%4.9894 of 5 stars2.95$99.89 32.6%22Positive News0.86%SNYSanofi$49.48-0.9%4.1592 of 5 stars3.11$62.00 25.3%9Positive News This page (NASDAQ:TMED) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersNew Banking Law #1582 Could Unlock $21 Trillion for AmericansDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T. Rowe Price Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share T. Rowe Price Health Care ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
